What is Scientific Technologies?
For over three decades, Scientific Technologies, operating as STChealth, has been a pivotal partner to Public Health initiatives and the private sector, dedicated to the eradication of vaccine-preventable diseases. The organization operates the largest vaccine informational exchange network across the USA. In response to the evolving COVID-19 pandemic, STChealth's solutions have been instrumental for pharmacies and healthcare providers, facilitating the administration of diagnostic tests, enabling the reporting of critical healthcare data to Public Health systems, and ensuring timely communication of test results to consumers. As a COVID vaccine emerges, STChealth's platforms are poised to support pharmacies and other immunization providers by delivering patient health history at the point of care and capturing essential healthcare data within their existing workflows.
How much funding has Scientific Technologies raised?
Scientific Technologies has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
What's next for Scientific Technologies?
The substantial enterprise-level funding received by Scientific Technologies positions it for significant expansion and continued innovation in public health technology. The recent strategic investment, in particular, suggests a focus on scaling its operations and enhancing its data exchange capabilities. This financial backing will likely fuel further development of its diagnostic and immunization support solutions, crucial for managing public health crises and routine vaccination programs. The company's established network and long-standing partnerships provide a strong foundation for leveraging this capital to solidify its market leadership and address emerging public health challenges.
See full Scientific Technologies company page
